Specifically, in vivo PAR1 activation causes mice to develop inflammatory bowel disease (IBD) whilst PAR1 inactivation or PAR1 deficiencies reduce the severity of IBD (33). The gene discussed is F2R; the disease is inflammatory bowel disease.